TRACON Pharmaceutical (TCON) – Analyst Comments
-
UPDATE: Baird Starts Tracon Pharmaceuticals (TCON) at Outperform
-
H.C. Wainwright Reiterates Buy Rating on Tracon Pharmaceuticals (TCON) Following Positive IDMC Review of ENVASARC Trial
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TCON Stock Lookup